Published in Am J Pathol on October 01, 1979
Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay. Br J Clin Pharmacol (1987) 0.99
Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages. Biochem J (1986) 0.85
Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis. PLoS One (2013) 0.77
Structural and biochemical changes in lungs of 3-methylindole-treated rats. Am J Pathol (1993) 0.75
Functions of lysosomes. Annu Rev Physiol (1966) 17.76
Metabolic patterns in three types of phagocytizing cells. J Cell Biol (1963) 8.92
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol (1975) 6.42
Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature (1973) 6.34
The release of prostaglandins from lung and other tissues. Ann N Y Acad Sci (1971) 4.91
Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82
Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature (1977) 4.75
Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol (1971) 4.09
The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem Pharmacol (1976) 3.88
A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol (1976) 3.86
Immunologic tissue injury mediated by neutrophilic leukocytes. Adv Immunol (1968) 3.82
Activated macrophages induce vascular proliferation. Nature (1977) 3.74
Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments. J Cell Biol (1974) 3.46
Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med (1977) 3.38
Control of lymphokine secretion by prostaglandins. Nature (1976) 3.34
A chemotactic role for prostaglandins released from polymorphonuclear leucocytes during phagocytosis. Br J Pharmacol (1975) 2.79
Lysosome. N Engl J Med (1965) 2.49
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
In vitro studies of immunologically induced secretion of mediators from cells and related phenomena. Adv Immunol (1973) 2.32
Secretory function of mononuclear phagocytes: a review. Am J Pathol (1976) 2.12
Prostaglandins in human seminal plasma. Prostaglandins and related factors 46. J Biol Chem (1966) 1.91
Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest (1977) 1.84
Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors. J Exp Med (1977) 1.67
Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. Science (1978) 1.60
Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence. FEBS Lett (1978) 1.55
Production of colony-stimulating factor by human macrophages. Lancet (1972) 1.43
Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis. Prostaglandins (1976) 1.40
Secretion of macrophage neutral proteinase is enhanced by colchicine. Proc Natl Acad Sci U S A (1976) 1.37
Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins (1977) 1.30
Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. Biochim Biophys Acta (1976) 1.25
Elastase secretion by peritoneal exudative and alveolar macrophages. J Exp Med (1977) 1.25
Hormonal stimulation of arachidonate release from isolated perfused organs. Relationship to prostaglandin biosynthesis. Prostaglandins (1977) 1.13
Effect of indomethacin and related drugs on the calcium ion-dependent secretion of lysosomal and other enzymes by neutrophil polymorphonuclear leucocytes in vitro. Br J Pharmacol (1977) 1.11
Regulation of immunity and inflammation by mediators from macrophages. Am J Pathol (1976) 1.03
Distribution of a macrophage-specific antigen. Cell Immunol (1972) 1.00
PGE2 and PGF2alpha biosynthesis in stimulated and nonstimulated peritoneal preparations containing macrophages. Prostaglandins (1977) 0.87
Prostaglandin production by human polymorphnuclear leucocytes during phagocytosis in vitro. Experientia (1977) 0.85
The role of prostaglandins in the control of the immune response to an autologous red blood cell antigen (Hb). Clin Immunol Immunopathol (1977) 0.79
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37
Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest (1988) 2.23
Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am J Pathol (1983) 1.76
Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol (1995) 1.68
Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats. Crit Care Med (1999) 1.43
Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins (1977) 1.30
Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages. Am J Pathol (1993) 1.30
Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr (1994) 1.30
Relationship of prostaglandin secretion by rabbit alveolar macrophages to phagocytosis and lysosomal enzyme release. Biochem J (1979) 1.23
Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest (1993) 1.22
Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol (1986) 1.15
Glucose tolerance and insulin action in rats with renovascular hypertension. Hypertension (1991) 1.15
Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. J Immunol (1991) 1.13
Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation (1987) 1.10
Effect of fasting on hyperoxic lung injury in mice. The role of glutathione. Am Rev Respir Dis (1990) 1.08
The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr (1997) 1.07
Leukotriene B4 biosynthesis by alveolar macrophages. Biochem Biophys Res Commun (1982) 1.06
Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim Biophys Acta (1998) 1.05
Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology (1994) 1.01
Two phospholipase pools for prostaglandin synthesis in macrophages. Nature (1981) 1.01
Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting. Biochem Biophys Res Commun (1997) 1.01
PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim Biophys Acta (1994) 1.00
Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. Br J Pharmacol (2000) 1.00
Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. J Immunol (2000) 1.00
Surgery for duplex kidneys with ectopic ureters: ipsilateral ureteroureterostomy versus polar nephrectomy. J Urol (1989) 0.97
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. Am J Pathol (1990) 0.96
Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins (1990) 0.95
Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor. Pediatr Res (1992) 0.95
Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. Biochem J (1997) 0.94
Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. Eur J Pharmacol (1986) 0.92
The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat. Gut (1999) 0.91
Endotoxin-resistant mice are protected from PAF-induced bowel injury and death. Role of TNF, complement activation, and endogenous PAF production. Dig Dis Sci (1995) 0.91
Neuronal nitric oxide synthase (NOS) regulates the expression of inducible NOS in rat small intestine via modulation of nuclear factor kappa B. FASEB J (2001) 0.90
Chemically induced renal hypertrophy in the rat. Lab Invest (1973) 0.90
Lipases and prostaglandin biosynthesis. Adv Prostaglandin Thromboxane Res (1978) 0.89
Platelet activating factor and endotoxin increase the enzyme activity and gene expression of type II phospholipase A2 in the rat intestine. Role of polymorphonuclear leukocytes. J Immunol (1996) 0.89
Rhabdomyogenesis in renal neoplasia of childhood. Am J Surg Pathol (1981) 0.89
Prostaglandins in histiocytosis-X. PG synthesis by histiocytosis-X cells. Am J Clin Pathol (1981) 0.89
Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr (1990) 0.88
Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. Am J Physiol Gastrointest Liver Physiol (2001) 0.88
Infantile sarcoma with intracytoplasmic filamentous inclusions: distinctive tumor of possible histiocytic origin. Cancer (1982) 0.88
Chronic insulin administration elevates blood pressure in rats. Hypertension (1994) 0.88
Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. Prostaglandins (1996) 0.87
Plasma cyclic guanosine monophosphate in chronic heart failure: hemodynamic and neurohormonal correlations and response to nitrate therapy. Clin Pharmacol Ther (1993) 0.86
Experimental necrotizing enterocolitis: the role of polymorphonuclear neutrophils. J Pediatr Surg (1991) 0.86
Endogenous bacterial toxins are required for the injurious action of platelet-activating factor in rats. Gastroenterology (1995) 0.86
Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether). Gastroenterology (1990) 0.85
Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism. N Engl J Med (1986) 0.85
Role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. Am J Physiol (1996) 0.85
Ventriculocholecystic shunt. A mortality report. Surg Neurol (1985) 0.84
Type I nitric oxide synthase (NOS) is the predominant NOS in rat small intestine. Regulation by platelet-activating factor. Biochim Biophys Acta (1999) 0.84
P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. Am J Physiol (1997) 0.83
Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res (1993) 0.83
Large-cell lymphoma. Diagnostic difficulties and case study. Am J Surg Pathol (1987) 0.83
Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin. Br J Pharmacol (2000) 0.83
Prostaglandin synthesis in different phases of phagocytosis in lung macrophages. Nature (1980) 0.83
Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. J Clin Invest (1986) 0.83
Circulating plasma platelet activating factor in persistent pulmonary hypertension of the newborn. Am Rev Respir Dis (1990) 0.82
The biosynthesis of leukotriene B4, the predominant lipoxygenase product in rabbit alveolar macrophages, is enhanced during immune activation. Biochim Biophys Acta (1985) 0.82
Serum and plasma stimulate prostaglandin production by alveolar macrophages. Prostaglandins (1983) 0.82
Wilms' tumor: its morphology in patients under one year of age. Cancer (1981) 0.82
PAF-induced bowel necrosis. Effects of vasodilators. Dig Dis Sci (1991) 0.81
Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. Gut (1988) 0.81
Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac. Gastroenterology (1986) 0.81
Effect of aspirin on experimental diabetic nephropathy. J Lab Clin Med (1987) 0.81
Intestinal trefoil factor binds to intestinal epithelial cells and induces nitric oxide production: priming and enhancing effects of mucin. Biochem J (1999) 0.81
Role of the lipoxygenase pathway in angiotensin II-mediated aldosterone biosynthesis in human adrenal glomerulosa cells. J Clin Endocrinol Metab (1988) 0.81
Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. Immunology (1999) 0.81
Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. J Physiol (1998) 0.80
Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med (1991) 0.80
Prostaglandin biosynthesis by a human macrophage-like cell line, U937. J Reticuloendothel Soc (1983) 0.80
Effect of plasma sodium concentration on diluting segment sodium reabsorption. Kidney Int (1974) 0.80
Hyperoxic lung damage in mice: appearance and bioconversion of peptide leukotrienes. J Appl Physiol (1985) (1988) 0.80
Bilateral renal dysplasia with features of nephroblastomatosis. Pediatr Pathol (1987) 0.79
Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells. Biochim Biophys Acta (1992) 0.79
Prostaglandins and the heart. Fed Proc (1979) 0.79
Therapeutic effect of calcium channel blockade in primary aldosteronism. J Clin Endocrinol Metab (1985) 0.79
Increase in plasma platelet-activating factor levels in enterally fed preterm infants. Biol Neonate (1993) 0.79
Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: effect of cycloheximide. Pediatr Res (1997) 0.78
Decreased phospholipase A2 activity and prostaglandin biosynthesis in Bacillus Calmette-Guérin-activated alveolar macrophages. Biochim Biophys Acta (1982) 0.78
Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. Br J Pharmacol (2001) 0.78
Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989. J Pharmacol Exp Ther (1989) 0.77
Molecular biology of human renin and its gene. Recent Prog Horm Res (1991) 0.77
Production of leukotrienes and thromboxane by resident and activated rat alveolar macrophages: a possible role of protein kinase C. J Lab Clin Med (1992) 0.77
Hypoxia, PAF, and necrotizing enterocolitis. Lipids (1991) 0.77
Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. J Heart Lung Transplant (1999) 0.76
Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease. Pharmacogenomics J (2006) 0.76
Antihypertensive agents in diabetic patients: great benefits, special risks. Arch Intern Med (1999) 0.75
Rabbit lymphocyte factors modulate prostaglandin biosynthesis in alveolar macrophages. Immunology (1985) 0.75
Bilateral adrenal ganglioneuroblastoma with neuromelanin. Clinical and pathologic observations. Cancer (1988) 0.75
Effects of dietary sodium on renin content during renal hypertrophy in uninephrectomized rats. Proc Soc Exp Biol Med (1974) 0.75
Cobra venom factor, an activator of the complement system, enhances the bowel necrosis induced by platelet-activating factor. Immunopharmacology (1988) 0.75
Familial factors in the antihypertensive response to lisinopril. Am J Hypertens (2001) 0.75
Thyrotoxicosis in a patient with secondary hypothyroidism. South Med J (1978) 0.75
Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure. Am J Cardiol (1987) 0.75
Selectivity of fatty acid release from macrophages following various stimuli. Kurume Med J (1985) 0.75
Prostaglandin secretion in rabbit alveolar macrophages and its relationship to phagocytosis. Chest (1979) 0.75
Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure. Circulation (1994) 0.75
Cardiac and renal lipases and prostaglandin biosynthesis. Lipids (1979) 0.75